Sangamo Therapeutics, Inc., a genomic medicine company, has announced a delay in their first quarter 2025 earnings call. Originally scheduled for 4:30 p.m. Eastern on May 12, it will now take place at 6:30 p.m. Eastern the same day. The registration and access link for the call remains unchanged.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.